• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成胆盐水解物 CamSA 对艰难梭菌感染仓鼠模型的影响。

Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection.

机构信息

Department of Physical and Life Sciences, Nevada State College, Henderson, Nevada, USA.

School of Life Sciences, University of Nevada, Las Vegas, Las Vegas, Nevada, USA.

出版信息

Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.02251-17. Print 2018 Oct.

DOI:10.1128/AAC.02251-17
PMID:30012758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6153836/
Abstract

infection (CDI) is the leading cause of antibiotic-associated diarrhea and has gained worldwide notoriety due to emerging hypervirulent strains and the high incidence of recurrence. We previously reported protection of mice from CDI using the antigerminant bile salt analog CamSA. Here we describe the effects of CamSA in the hamster model of CDI. CamSA treatment of hamsters showed no toxicity and did not affect the richness or diversity of gut microbiota; however, minor changes in community composition were observed. Treatment of challenged hamsters with CamSA doubled the mean time to death, compared to control hamsters. However, CamSA alone was insufficient to prevent CDI in hamsters. CamSA in conjunction with suboptimal concentrations of vancomycin led to complete protection from CDI in 70% of animals. Protected animals remained disease-free at least 30 days postchallenge and showed no signs of colonic tissue damage. In a delayed-treatment model of hamster CDI, CamSA was unable to prevent infection signs and death. These data support a putative model in which CamSA reduces the number of germinating spores but does not keep all of the spores from germinating. Vancomycin halts division of any vegetative cells that are able to grow from spores that escape CamSA.

摘要

感染(CDI)是抗生素相关性腹泻的主要原因,由于新兴的高毒力菌株和高复发率,它在全球范围内引起了关注。我们之前报道了使用抗萌发胆汁盐类似物 CamSA 保护小鼠免受 CDI 的侵害。在这里,我们描述了 CamSA 在仓鼠 CDI 模型中的作用。CamSA 处理仓鼠没有显示出毒性,也不会影响肠道微生物群落的丰富度或多样性;然而,观察到群落组成有轻微变化。与对照仓鼠相比,用 CamSA 处理受挑战的仓鼠将平均死亡时间延长了一倍。然而,CamSA 单独使用不足以预防仓鼠 CDI。CamSA 与低浓度万古霉素联合使用可使 70%的动物完全免受 CDI 的侵害。受保护的动物在挑战后至少 30 天内保持无病状态,并且没有结肠组织损伤的迹象。在仓鼠 CDI 的延迟治疗模型中,CamSA 无法预防感染迹象和死亡。这些数据支持了一个假设模型,即 CamSA 减少了发芽孢子的数量,但不能阻止所有孢子发芽。万古霉素阻止任何能够从逃避 CamSA 的孢子生长的营养细胞分裂。

相似文献

1
Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection.合成胆盐水解物 CamSA 对艰难梭菌感染仓鼠模型的影响。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.02251-17. Print 2018 Oct.
2
A new strategy for the prevention of Clostridium difficile infection.一种预防艰难梭菌感染的新策略。
J Infect Dis. 2013 May 15;207(10):1498-504. doi: 10.1093/infdis/jit068. Epub 2013 Feb 18.
3
An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.一种苯胺取代的胆盐类似物可保护小鼠和仓鼠免受多种艰难梭菌菌株的感染。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0143521. doi: 10.1128/AAC.01435-21. Epub 2021 Nov 15.
4
Fate of ingested Clostridium difficile spores in mice.摄入的艰难梭菌孢子在小鼠体内的命运。
PLoS One. 2013 Aug 30;8(8):e72620. doi: 10.1371/journal.pone.0072620. eCollection 2013.
5
Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.CamSA 的药代动力学,一种预防艰难梭菌感染的潜在化合物。
Biochem Pharmacol. 2021 Jan;183:114314. doi: 10.1016/j.bcp.2020.114314. Epub 2020 Nov 3.
6
Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.奥他万古霉素不会诱导仓鼠或人类肠道模型中艰难梭菌的发芽和毒素产生。
J Antimicrob Chemother. 2012 Dec;67(12):2919-26. doi: 10.1093/jac/dks309. Epub 2012 Aug 16.
7
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.用于艰难梭菌感染(CDI)的SMT19969:在CDI仓鼠模型中与非达霉素和万古霉素相比的体内疗效
J Antimicrob Chemother. 2015;70(6):1757-62. doi: 10.1093/jac/dkv005. Epub 2015 Feb 3.
8
Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.艰难梭菌感染啮齿动物模型中的疾病进展与消退以及抗毒素抗体和万古霉素的影响
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6471-6482. doi: 10.1128/AAC.00974-16. Print 2016 Nov.
9
Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.口腔 fidaxomicin 给药对小鼠肠道微生物群和艰难梭菌定植易感性的影响。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02112-17. Print 2018 May.
10
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.评估 NVB302 与万古霉素在体外艰难梭菌感染人类肠道模型中的活性。
J Antimicrob Chemother. 2013 Jan;68(1):168-76. doi: 10.1093/jac/dks359. Epub 2012 Sep 10.

引用本文的文献

1
New treatment approaches for infections: alternatives to antibiotics and fecal microbiota transplantation.感染的新治疗方法:抗生素和粪便微生物群移植的替代品。
Gut Microbes. 2024 Jan-Dec;16(1):2337312. doi: 10.1080/19490976.2024.2337312. Epub 2024 Apr 9.
2
The design, synthesis, and inhibition of Clostridioides difficile spore germination by acyclic and bicyclic tertiary amide analogs of cholate.胆酸盐中环型和双环三级酰胺类似物的设计、合成及对艰难梭菌孢子发芽的抑制作用。
Eur J Med Chem. 2023 Dec 5;261:115788. doi: 10.1016/j.ejmech.2023.115788. Epub 2023 Sep 4.
3
CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models.CDBN-YGXZ,一种新型小分子药物,在艰难梭菌感染和复发的小鼠和仓鼠感染模型中显示出疗效。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0170422. doi: 10.1128/aac.01704-22. Epub 2023 Apr 13.
4
Mechanism of germination inhibition of Clostridioides difficile spores by an aniline substituted cholate derivative (CaPA).一种取代胆酸的苯胺衍生物(CaPA)对艰难梭菌孢子发芽的抑制机制。
J Antibiot (Tokyo). 2023 Jun;76(6):335-345. doi: 10.1038/s41429-023-00612-3. Epub 2023 Apr 4.
5
Clostridioides difficile bile salt hydrolase activity has substrate specificity and affects biofilm formation.艰难梭菌胆汁盐水解酶活性具有底物特异性,并影响生物膜的形成。
NPJ Biofilms Microbiomes. 2022 Nov 30;8(1):94. doi: 10.1038/s41522-022-00358-0.
6
Efficacy of Omadacycline or Vancomycin Combined With Germinants for Preventing Clostridioides difficile Relapse in a Murine Model.奥马环素或万古霉素联合杀菌剂预防艰难梭菌复发的小鼠模型疗效。
J Infect Dis. 2023 Mar 1;227(5):622-630. doi: 10.1093/infdis/jiac324.
7
A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection.高碳水化合物饮食延长了肠道菌群失调和艰难梭菌定植,并增加了感染仓鼠模型的延迟死亡率。
Microbiol Spectr. 2022 Aug 31;10(4):e0180421. doi: 10.1128/spectrum.01804-21. Epub 2022 Jun 16.
8
Studies on the Importance of the 7α-, and 12α- hydroxyl groups of N-Aryl-3α,7α,12α-trihydroxy-5β-cholan-24-amides on their Antigermination Activity Against a Hypervirulent Strain of Clostridioides (Clostridium) difficile.研究 N-芳基-3α,7α,12α-三羟基-5β-胆烷-24-酰胺的 7α-和 12α-羟基对其抗艰难梭菌(梭状芽孢杆菌)超强毒力株致芽胞作用的重要性。
Bioorg Med Chem. 2021 Dec 15;52:116503. doi: 10.1016/j.bmc.2021.116503. Epub 2021 Nov 10.
9
Clostridioides difficile spore germination: initiation to DPA release.艰难梭菌孢子萌发:从起始到 DPA 释放。
Curr Opin Microbiol. 2022 Feb;65:101-107. doi: 10.1016/j.mib.2021.11.001. Epub 2021 Nov 19.
10
: innovations in target discovery and potential for therapeutic success.: 目标发现的创新和治疗成功的潜力。
Expert Opin Ther Targets. 2021 Nov;25(11):949-963. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 2.

本文引用的文献

1
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.开发一种含二元毒素的新型疫苗,用于预防艰难梭菌疾病,对NAP1菌株具有更高疗效。
PLoS One. 2017 Jan 26;12(1):e0170640. doi: 10.1371/journal.pone.0170640. eCollection 2017.
2
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.阿克曼氏菌黏液亚种的纯化膜蛋白或巴氏杀菌细菌可改善肥胖和糖尿病小鼠的代谢。
Nat Med. 2017 Jan;23(1):107-113. doi: 10.1038/nm.4236. Epub 2016 Nov 28.
3
CdtR Regulates TcdA and TcdB Production in Clostridium difficile.CdtR调节艰难梭菌中TcdA和TcdB的产生。
PLoS Pathog. 2016 Jul 14;12(7):e1005758. doi: 10.1371/journal.ppat.1005758. eCollection 2016 Jul.
4
DADA2: High-resolution sample inference from Illumina amplicon data.DADA2:从Illumina扩增子数据进行高分辨率样本推断。
Nat Methods. 2016 Jul;13(7):581-3. doi: 10.1038/nmeth.3869. Epub 2016 May 23.
5
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.重组艰难梭菌鞭毛蛋白FliC的免疫原性和保护效力
Emerg Microbes Infect. 2016 Feb 3;5(2):e8. doi: 10.1038/emi.2016.8.
6
From in vitro Experiments to in vivo and Clinical Studies; Pros and Cons.从体外实验到体内及临床研究;利弊分析
Curr Drug Discov Technol. 2015;12(4):218-24. doi: 10.2174/1570163813666160114093140.
7
Immunogenicity and protective efficacy of Clostridium difficile spore proteins.艰难梭菌芽孢蛋白的免疫原性和保护效力
Anaerobe. 2016 Feb;37:85-95. doi: 10.1016/j.anaerobe.2015.12.001. Epub 2015 Dec 11.
8
Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.仅用万古霉素治疗小鼠艰难梭菌感染与用万古霉素和甲硝唑联合治疗一样有效。
BMJ Open Gastroenterol. 2015 Nov 2;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015.
9
Isolation and Identification of Clostridium difficile Using ChromID C. difficile Medium Combined With Gram Staining and PRO Disc Testing: A Proposal for a Simple Culture Process.使用艰难梭菌显色培养基结合革兰氏染色和PRO药敏纸片法分离鉴定艰难梭菌:一种简单培养方法的建议
Ann Lab Med. 2015 Jul;35(4):404-9. doi: 10.3343/alm.2015.35.4.404. Epub 2015 May 21.
10
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.确定艰难梭菌感染期间TcdA和TcdB在局部胃肠道疾病、全身器官损伤及宿主反应中的作用。
mBio. 2015 Jun 2;6(3):e00551. doi: 10.1128/mBio.00551-15.